Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
OA08 - Mesothelioma: Immunotherapy and microRNA for Diagnosis and Treatment
- 15:15 - 16:45
- 9/24/2018
- Location: Room 201 BD
- Type: Oral Abstract Session
- Track: Mesothelioma
-
+
OA08.01 - Long-Term Efficacy and Safety of Nivolumab in Second- or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study)
15:15 - 15:25 | Presenter: Takashi Nakano | Author(s): Morihito Okada, Takashi Kijima, Keisuke Aoe, Tatsuya Kato, Nobukazu Fujimoto, Kazuhiko Nakagawa, Yuichiro Takeda, Toyoaki Hida, Kuninobu Kanai, Fumio Imamura, Satoshi Oizumi, Toshiaki Takahashi, Mitsuhiro Takenoyama, Hiroshi Tanaka, Yuichiro Ohe
- Abstract
Loading... -
+
OA08.02 - DREAM - A Phase 2 Trial of Durvalumab with First Line Chemotherapy in Mesothelioma: Final Result
15:25 - 15:35 | Presenter: Anna K. Nowak | Author(s): Peey-Sei Kok, Willem Joost Lesterhuis, Brett G.M Hughes, Chris Brown, Steven Chuan-Hao Kao, Deme Karikios, Thomas John, Nick Pavlakis, Kenneth O’byrne, Sonia Yip, Wei-Sen Lam, Karen Briscoe, Chris S. Karapetis, Martin R Stockler
- Abstract
Loading... -
+
OA08.03 - Phase II Trial of Pembrolizumab (NCT02399371) In Previously-Treated Malignant Mesothelioma (MM): Final Analysis
15:35 - 15:45 | Presenter: Arpita Desai | Author(s): Theodore Karrison, Pamela Rose, Yi-Hung Carol Tan, Bianca Hill, Erika Pemberton, Christopher Straus, Tanguy Seiwert, Hedy Lee Kindler
- Abstract
Loading... -
+
OA08.04 - Discussant - OA 08.01, OA 08.02, OA 08.03
15:45 - 16:00 | Presenter: Thomas John
- Abstract
No abstract available for this presentation
-
+
OA08.05 - Quantifying Tumour Infiltrating Lymphocytes (TILs) in Malignant Pleural Mesothelioma (MPM) -Defining the Hot, the Warm and the Cold Tumours.
16:00 - 16:10 | Presenter: Thomas John | Author(s): Bibhusal Thapa, Marzena Walkeiwicz, Gareth Rivalland, Carmel Murone, Khashayar Asadi, Stephen Arthur Barnett, Simon Knight, Shona Hendry, Prudence Russell
- Abstract
Loading... -
+
OA08.06 - Tumour Suppressor MicroRNAs Modulate Drug Resistance by Targeting Anti-Apoptotic Pathways in Malignant Pleural Mesothelioma (MPM)
16:10 - 16:20 | Presenter: Yuen Yee Cheng | Author(s): Marissa Williams, Monica Phimmachanh, Patrick Winata, Glen Reid
- Abstract
Loading... -
+
OA08.07 - In Silico Discovery of Unannotated miRNAs in Malignant Pleural Mesothelioma Reveals Novel Tissue-of-Origin Markers
16:20 - 16:30 | Presenter: Brenda C. Minatel | Author(s): Erin A Marshall, Christine Anderson, Kevin W. Ng, Katey S.S. Enfield, Adam P Sage, Zhaolin Xu, Wan Lam, Victor D Martinez
- Abstract
Loading... -
+
OA08.08 - Discussant - OA 08.05, OA 08.06, OA 08.07
16:30 - 16:45 | Presenter: Emanuela Felley-Bosco
- Abstract
No abstract available for this presentation
-
+
OA09 - Prevention and Cessation
- 15:15 - 16:45
- 9/24/2018
- Location: Room 205 BD
- Type: Oral Abstract Session
- Track: Prevention and Tobacco Control
-
+
OA09.01 - 5As to 3As: Evolution of the Systematic Approach to Smoking Cessation in Ontario’s Regional Cancer Centres
15:15 - 15:25 | Presenter: William Kenneth Evans | Author(s): Erin Cameron, Mohammad Haque, Naomi Schwartz, Sahara Khan, Rebecca Truscott
- Abstract
Loading... -
+
OA09.02 - Acceptance of Smoking Cessation Services in Cancer Care Ontario’s Lung Cancer Screening Pilot for People at High Risk
15:25 - 15:35 | Presenter: William Kenneth Evans | Author(s): Gail Elizabeth Darling, Beth Miller, Erin Cameron, Monica Yu, Martin Tammemägi
- Abstract
Loading... -
+
OA09.03 - Discussions Between Health Professionals and Smokers About E-Cigarettes: Results from the ITC Policy Evaluation Project
15:35 - 15:45 | Presenter: Shannon Gravely | Author(s): James F Thrasher, K. Michael Cummings, Janine Ouimet, Ann McNeill, Gang Meng, Eric N. Lindblom, Ruth Loewen, Richard O’connor, Mary E. Thompson, Sara C. Hitchman, David Hammond, Bryan W. Heckman, Ron Borland, Hua Hie Yong, Tara Elton-Marshall, Maansi Bansal Travers, Coral Gartner, Geoffrey T. Fong
- Abstract
Loading... -
+
OA09.04 - Discussant - OA 09.01, OA 09.02, OA 09.03
15:45 - 16:00 | Presenter: Betty Tong
- Abstract
No abstract available for this presentation
-
+
OA09.05 - Potential Reduction in Lung Cancer Mortality in the US from 2015-2065: A Comparative Modeling Approach
16:00 - 16:10 | Presenter: Jihyoun Jeon | Author(s): Theodore R. Holford, David T. Levy, Eric J. Feuer, Pianpian Cao, Jamie Tam, Lauren Clarke, John Clarke, Chung Yin Kong, Rafael Meza
- Abstract
Loading... -
+
OA09.06 - Molecular Alterations and Estimated Indoor Radon in NSCLC Patients from the French National Cancer Institute Registry: Radon France Study
16:10 - 16:20 | Presenter: Laura Mezquita | Author(s): Fabrice Barlesi, Edouard Auclin, David Planchard, Angela Botticella, Anas Gazzah, Pernelle Lavaud, Frank Aboubakar Nana, Cecile Lepéchoux, Benjamin Besse
- Abstract
Loading... -
+
OA09.07 - Association Between Outdoor Air Pollution And Lung Cancer in Female Never Smokers
16:20 - 16:30 | Presenter: Renelle L Myers | Author(s): Michael Brauer, Sim Ladhar, Sukhinder Atkar-Khattra, John Yee, Cheryl Ho, Anna McGuire, Kyle Grant, Alex Lee, Barbara Melosky, Sophie Sun, Martin Tammemägi, Stephen Lam
- Abstract
Loading... -
+
OA09.08 - Discussant - OA 09.05, OA 09.06, OA 09.07
16:30 - 16:45 | Presenter: Douglas Arenberg
- Abstract
No abstract available for this presentation
-
+
PC03 - Controversies in Management of Resectable Thymoma
- 15:15 - 16:45
- 9/24/2018
- Location: Room 205 AC
- Type: Pro-Con Session
- Track: Thymoma/Other Thoracic Malignancies
-
+
PC03.01 - Post-Operative Radiation Therapy or NOT: PRO
15:15 - 15:25 | Presenter: Conrad B Falkson
- Abstract
No abstract available for this presentation
-
+
PC03.02 - Post-Operative Radiation Therapy or NOT: CON
15:25 - 15:35 | Presenter: Daniel Gomez
- Abstract
No abstract available for this presentation
-
+
PC03.03 - Discussion
15:35 - 15:45
- Abstract
No abstract available for this presentation
-
+
PC03.04 - Debate on Standard Surgical Approaches - Minimally Invasive Thymectomy
15:45 - 15:55 | Presenter: Shaf Keshavjee
- Abstract
No abstract available for this presentation
-
+
PC03.05 - Debate on Standard Surgical Approaches - Open Thymectomy
15:55 - 16:05 | Presenter: Meinoshin Okumura
- Abstract
No abstract available for this presentation
-
+
PC03.06 - Discussion
16:05 - 16:15
- Abstract
No abstract available for this presentation
-
+
PC03.07 - Adjuvant Chemotherapy for Thymic Carcinoma - YES
16:15 - 16:25 | Presenter: Giulia Pasello
- Abstract
No abstract available for this presentation
-
+
PC03.08 - Adjuvant Chemotherapy for Thymic Carcinoma - NO
16:25 - 16:35 | Presenter: Sukhmani Kaur Padda
- Abstract
No abstract available for this presentation
-
+
PC03.09 - Discussion
16:35 - 16:45
- Abstract
No abstract available for this presentation
-
+
PC04 - Targeted Therapy for NSCLC
- 15:15 - 16:45
- 9/24/2018
- Location: Room 106
- Type: Pro-Con Session
- Track: Targeted Therapy
-
+
PC04.01 - Optimal Sequencing of EGFR TKI Therapy (Gefitinib/Erlotinib/Afatinib First versus Osimertinib First)
15:15 - 15:27 | Presenter: James Chih-Hsin Yang
- Abstract
No abstract available for this presentation
-
+
PC04.02 - Optimal Sequencing of EGFR TKI Therapy - 3rd Generation First
15:27 - 15:39 | Presenter: Karen L. Reckamp
- Abstract
No abstract available for this presentation
-
+
PC04.03 - Adjuvant Targeted Therapy for pts with Genomic Alterations - Yes
15:39 - 15:51 | Presenter: Shun Lu
- Abstract
No abstract available for this presentation
-
+
PC04.04 - Adjuvant Targeted Therapy for pts with Genomic Alterations - No
15:51 - 16:03 | Presenter: Lecia Sequist
- Abstract
No abstract available for this presentation
-
+
PC04.05 - NGS/Whole Exome Sequencing for Routine Use
16:03 - 16:15 | Presenter: Daniel S.W. Tan
- Abstract
No abstract available for this presentation
-
+
PC04.06 - Focused Panels for Molecular Profiling for Routine Use
16:15 - 16:27 | Presenter: Fernando Lopez-Rios
- Abstract
No abstract available for this presentation
-
+
PC04.07 - Q&A
16:27 - 16:45
- Abstract
No abstract available for this presentation
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-01 - ROS1-Positive Non-Small Cell Lung Cancer: Real-World Data in Korea
16:45 - 18:00 | Presenter: Beung Chul Ahn | Author(s): Sehhoon Park, Sung Won Lim, Hye Ryun Kim, Min Hee Hong, Byoung Chul Cho, Myung-Ju Ahn
- Abstract
Loading... -
+
P1.01-02 - Long-Term Outcomes with First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 3-Year Follow-Up from CheckMate 012
16:45 - 18:00 | Presenter: Scott J Antonia | Author(s): Scott N. Gettinger, Hossein Borghaei, Jonathan W. Goldman, Julie R. Brahmer, Neal E. Ready, David E Gerber, Laura Q Chow, Rosalyn Juergens, Scott A. Laurie, Frances A Shepherd, Xuemei Li, Ang Li, William J. Geese, Matthew D. Hellmann
- Abstract
Loading... -
+
P1.01-03 - Effect of Prophylactic Cranial Irradiation on Cognitive Function and QoL in NSCLC Patients at High Risk of Brain Metastases
16:45 - 18:00 | Presenter: Oscar Arrieta | Author(s): Ana Gonzalez-Ling, Federico Maldonado, Miguel Angel Salinas Padilla, Manuel Arguelles, Laura-Alejandra Ramírez-Tirado, Zyanya Lucia Zatarain-Barrón, Feliciano Barron, Luis Antonio Cabrera-Miranda, Diana Flores, Andrés F. Cardona
- Abstract
Loading... -
+
P1.01-04 - Treatment Patterns and Overall Survival Following Biomarker Testing in Real-World Advanced NSCLC Patients
16:45 - 18:00 | Presenter: Fabrice Barlesi | Author(s): Luis Paz-Ares, Damian R. Page, Ashwini Shewade, Peter Lambert, Tariq I. Mughal, Laurie M. Gay, Mohsen Khorshid, Brandon Arnieri, William Capra, Stefan Foser, Céline Mascaux, Lukas Bubendorf, Lisa I. Wang
- Abstract
Loading... -
+
P1.01-05 - Metformin in Combination with Crizotinib for The Treatment of EML4-ALK+ Lung Cancer.
16:45 - 18:00 | Presenter: Abigail Bland | Author(s): Mhairi Nimick, John Ashton
- Abstract
Loading... -
+
P1.01-06 - Plinabulin, a Novel Immuno-Oncology Agent Mitigates Docetaxel Chemotherapy -Induced-Neutropenia and -Thrombocytopenia in NSCLC Patients.
16:45 - 18:00 | Presenter: Douglas W. Blayney | Author(s): Stephan Ogenstad, Yuankai Shi, Qingyuan Zhang, Lihua Du, Lan Huang, Ramon Mohanlal
- Abstract
Loading... -
+
P1.01-07 - Immune-Related Pneumonitis in NSCLC Patients Treated with Immune Checkpoint Inhibitors (ICI): Impact of Previous Thoracic Radiotherapy
16:45 - 18:00 | Presenter: Angela Botticella | Author(s): Tony Ibrahim, Laura Mezquita, Lizza Hendriks, Jerome Le Pavec, Roberto Ferrara, Caroline Caramella, Jordi Remon, Stephane Champiat, Jean-Marie Michot, Pernelle Lavaud, Frank Aboubakar Nana, Pierre Gustin, David Planchard, Anas Gazzah, Aurélien Marabelle, Deutsch Eric, Benjamin Besse, Cecile Le Pechoux
- Abstract
Loading... -
+
P1.01-08 - Hyperresponsive Disease: A New Pattern of Response in NSCLC Patients Treated by Anti-PD-1/PD-L1
16:45 - 18:00 | Presenter: Nicole Bouchard | Author(s): Marie-Pier Gauthier
- Abstract
Loading... -
+
P1.01-09 - Pembrolizumab Plus Ipilimumab or Placebo in 1L Metastatic NSCLC with PD-L1 Tumor Proportion Score (TPS) ≥50%: KEYNOTE-598
16:45 - 18:00 | Presenter: Michael Boyer | Author(s): Jessica McLean, Lu Xu, Ayman Samkari, David P Carbone
- Abstract
Loading... -
+
P1.01-10 - Stage III Non-Small Cell Lung Cancer Clinical Outcomes with Surgical Resection After Definitive Neoadjuvant Chemoradiotherapy
16:45 - 18:00 | Presenter: Ilaria Caturegli | Author(s): Melissa Ana Liriano Vyfhuis, Whitney Burrows, Mohan Suntharalingam, Shahed Badiyan, Katherine Scilla, Shamus R Carr, Joseph Friedberg, Gavin Henry, Shelby Stewart, Charles B. Simone, Pranshu Mohindra
- Abstract
Loading... -
+
P1.01-100 - Concurrent Brain Radiotherapy and EGFR-TKI Have Better Survival Benefits in Patients with Brain Metastases from EGFR-Mutant NSCLC
16:45 - 18:00 | Presenter: Yaping Xu | Author(s): Yaoyao Zhu, Yun Chen, Shuiyun Han, Xiaozhen Ying, Xiaojiang Sun
- Abstract
Loading... -
+
P1.01-101 - Survival Benefit of Sequential Therapy in ALK Positive Olioprogressive NSCLC Patients After Crizotinib Resistance
16:45 - 18:00 | Presenter: Haiyan Xu | Author(s): Di Ma, Guangjian Yang, Junling Li, Xuezhi Hao, Puyuan Xing, Lu Yang, Yan Wang
- Abstract
Loading... -
+
P1.01-102 - Retrospective Analysis of Immune Checkpoint Inhibitors in Patients with EGFR Mutated Non-Small Cell Lung Cancer in a Japanese Cohort
16:45 - 18:00 | Presenter: Tadaaki Yamada | Author(s): Shinsuke Shiotsu, Keiko Tanimura, Taishi Harada, Yutaka Kubota, Takayuki Takeda, Satoshi Watanabe, Junji Uchino, Koichi Takayama
- Abstract
Loading... -
+
P1.01-103 - Leukocyte Telomere Length as a Novel Biomarker in Advanced Lung Adenocarcinoma Patients Treated with Gefitinib
16:45 - 18:00 | Presenter: Ming Yang | Author(s): Ji Li, Nasha Zhang, Jibing Liu, Huaixin Xing
- Abstract
Loading... -
+
P1.01-104 - Updated Phase I Results of Carboplatin, Pemetrexed and Exemestane in Postmenopausal Women with Metastatic Non-Squamous NSCLC
16:45 - 18:00 | Presenter: Patricia A. Young | Author(s): Diana C. Marquez, Zorawar S. Noor, Rena Callahan, Benjamin L. Jones, Deborah J. Wong, Jonathan W. Goldman, Steven Applebaum, Rebecca Rausch, Christian Yanes, Stephanie Bueno, Natalia Garban, David Elashoff, Edward B Garon, Richard Pietras
- Abstract
Loading... -
+
P1.01-105 - Lung Cancer Patients with Concurrent EGFR and MET Mutations: A Retrospective Analysis of 29 Cases
16:45 - 18:00 | Presenter: Zhaoxia Wang | Author(s): Mingming Yuan, Renhua Guo, Gen Lin, Xinghao Ai, Xiaorong Dong, Rongrong Chen, Xuefeng Xia
- Abstract
Loading... -
+
P1.01-106 - Pembrolizumab Randomized, Phase 1 Study in Chinese Patients with Advanced NSCLC: KEYNOTE-032.
16:45 - 18:00 | Presenter: Li Zhang | Author(s): Yuxiang Ma, Wenfeng Fang, Shuang Xie, Jun Ge, HaoJin Zhou
- Abstract
Loading... -
+
P1.01-107 - The Impact of Anlotinib on Quality of Life in Patients with Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)
16:45 - 18:00 | Presenter: Li Zhang | Author(s): Xiaoyan Si, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Baohui Han, Kai Li, Qiming Wang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Weiqiang Chen, Xiuwen Wang, Yi Luo, Kejun Nan, Faguang Jin, Baolan Li, Yinlan Chen, Jianying Zhou, Donglin Wang
- Abstract
Loading... -
+
P1.01-108 - Management of Anlotinib-Related Adverse Events: Data From ALTER 0303
16:45 - 18:00 | Presenter: Li Zhang | Author(s): Xiaoyan Si, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Baohui Han, Kai Li, Qiming Wang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Weiqiang Chen, Xiuwen Wang, Yi Luo, Kejun Nan, Faguang Jin, Baolan Li, Yinlan Chen, Jianying Zhou, Donglin Wang
- Abstract
Loading... -
+
P1.01-109 - Phase I Study of Apatinib Plus Gefitinib as First-Line Therapy in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Hongyun Zhao | Author(s): Zhonghan Zhang, Su Li, Wenfeng Fang, Yuxiang Ma, Yang Zhang, Yunpeng Yang, Fan Luo, Yan Huang, Li Zhang
- Abstract
Loading... -
+
P1.01-11 - Named Patient Use Program for Afatinib in Advanced NSCLC with Progression on Prior Therapy: Experience from Asian Centers
16:45 - 18:00 | Presenter: Keunchil Park | Author(s): Gee-Chen Chang, Chi Leung Lam, Chun-Ming Tsai, Yuh-Min Chen, Jin-Yuan Shih, Shyam Aggarwal, Shuhang Wang, Sang-We Kim, Young-Chul Kim, Ibrahim Wahid, Rubi Li, Wan-Teck Lim, Virote Sriuranpong, Tsz Tong Chan, Robert M Lorence, Philippe Carriere, Christina Raabe, Agnieszka Cseh
- Abstract
Loading... -
+
P1.01-110 - Three Specific HER2 Mutations Predict Favorable Outcomes in Advanced Lung Cancer Patients Treated with Afatinib
16:45 - 18:00 | Presenter: Shen Zhao | Author(s): Wenfeng Fang, Yunpeng Yang, Li Zhang
- Abstract
Loading... -
+
P1.01-111 - EGFR exon20 Insertion Patients Treated with First-Line Chemotherapy in Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Chao Zhao | Author(s): Xuefei Li, Chunxia Su, Xiaoxia Chen, Shengxiang Ren, Caicun Zhou
- Abstract
Loading... -
+
P1.01-112 - Osimertinib vs Standard of Care (SoC) EGFR-TKI as First-Line Treatment in Chinese Patients With EGFRm Advanced NSCLC
16:45 - 18:00 | Presenter: Caicun Zhou | Author(s): Ying Cheng, Yong He, Wei Li, Helong Zhang, Qing Zhou, Buhai Wang, Chunling Liu, Suresh S. Ramalingam, Andrew Walding, Matilde Saggese, Jia Wang, Minhao Fan, Yi-Long Wu
- Abstract
Loading... -
+
P1.01-113 - Analysis of Clinicopathological Features and Clinical Efficacy of Crizotinib in ROS1 Positive Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Youcai Zhu | Author(s): Xiaofeng Li, Lixin Wu, Huafei Chen, Wenxian Wang, Chunwei Xu, Meiyu Fang, Jianfa Shen, Kaiqi Du, Wu Zhuang, Yanping Chen, Gang Chen
- Abstract
Loading... -
+
P1.01-12 - SWItch Maintenance PEmbrolizumab in Patients with Metastatic Non Small Cell Lung Cancer (SWIPE)
16:45 - 18:00 | Presenter: Haris Charalambous | Author(s): Flora Kyriacou, Ioannis Stylianou, Paris Vogazianos, Maria Allayioti, Demetris Vomvas, Nikos Katodritis, George Orphanos
- Abstract
Loading... -
+
P1.01-13 - A Study of S-1 Plus Cisplatin in Patients with Advanced Non-Small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Yuh-Min Chen | Author(s): Chun-Liang Lai, Yu-Feng Wei, Te-Chun Hsia, Gee-Chen Chang
- Abstract
Loading... -
+
P1.01-14 - Immunotherapy (I) for Advanced, Pre-Treated, Non-Squamous NSCLC (APNS-NSCLC). Preliminary Data of a Pooled Analysis
16:45 - 18:00 | Presenter: Lorenza Landi | Author(s): Davide Tassinari, Chiara Cherubini, Michela Pilati, Maximilian Papi, Stefania Vittoria Luisa Nicoletti, Luigi Arcangelo Lazzari Agli
- Abstract
Loading... -
+
P1.01-15 - ROS1-Rearranged Non-Small Cell Lung Cancer Is Associated with High Rate of Venous Thromboembolism: Analysis of The METROS Trial
16:45 - 18:00 | Presenter: Biagio Ricciuti | Author(s): Rita Chiari, Lorenza Landi, Anna Maira Morelli, Angelo Delmonte, Gianluca Spitalieri, Diego Cortinovis, Francesco Facchinetti, Sara Pilotto, Claudio Verusio, Antonio Chella, Laura Bonanno, Domenico Galetta, Federico Cappuzzo
- Abstract
Loading... -
+
P1.01-16 - First-Line Pembrolizumab With or Without Chemotherapy in PD-L1 positive NSCLC: A Network Meta-Analysis of Randomized Trials.
16:45 - 18:00 | Presenter: Mark K. Doherty | Author(s): Seanthel Delos Santos, Amanda Putri Rahmadian, Kelvin K.W. Chan
- Abstract
Loading... -
+
P1.01-17 - Immune-Related Adverse Events in Patients with Metastatic Non-Small Cell Lung Cancer: Sex Differences and Response to Therapy.
16:45 - 18:00 | Presenter: Narjust Duma | Author(s): Abdel-Ghani M. Azzouqa, Siddhartha Yadav, Katherine Hoversten, Clay T. Reed, Andrea N. Sitek, Elizabeth A. Enninga, Jonas Paludo, Jesus Vera Aguilera, Yanyan Lou, Julian R. Molina, Konstantinos Leventakos, Lisa A. Kottschade, Haidong Dong, Aaron S. Mansfield, Rami Manochakian, Roxana S Dronca, Alex Adjei
- Abstract
Loading... -
+
P1.01-18 - Immunosenescence Correlates with Progression upon PD-(L)-1 Blockade (IO) in Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients.
16:45 - 18:00 | Presenter: Roberto Ferrara | Author(s): Marie Naigeon, Eduard Auclin, Boris Duchemann, Lydie Cassard, Jouniaux Medhi, Lisa Boselli, Jonathan Grivel, Aude Desnoyer, Laura Mezquita, Frank Aboubakar Nana, Lizza Hendriks, David Planchard, Caroline Caramella, Jordi Remon, Maud Ngocamus, Claudio Nicotra, Benjamin Besse, Nathalie Chaput
- Abstract
Loading... -
+
P1.01-19 - Efficacy of Tyrosine Kinase Inhibitors in EGFR Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases.
16:45 - 18:00 | Presenter: Ronan Flippot | Author(s): Eduard Auclin, Pamela Biondani, Emilie Le Rhun, Julien Adam, David Planchard, Caroline Caramella, Cecile Le Pechoux, Ludovic Lacroix, Anas Gazzah, Laura Mezquita, Benjamin Besse
- Abstract
Loading... -
+
P1.01-20 - Phase III Study Comparing Gefitinib (G) to Gefitinib Combined with Carboplatin and Pemetrexed (GCP) for NSCLC with EGFR Mutations (NEJ009).
16:45 - 18:00 | Presenter: Tatsuro Fukuhara | Author(s): Akira Inoue, Satoshi Morita, Shunichi Sugawara, Yukio Hosomi, Satoshi Ikeda, Akihiko Gemma, Kazuhisa Takahashi, Yuka Fujita, Toshiyuki Harada, Koichi Minato, Kei Takamura, Kunihiko Kobayashi, Toshihiro Nukiwa
- Abstract
Loading... -
+
P1.01-21 - Safety of Durvalumab Retreatment in Advanced NSCLC Patients Who Progressed Following Initial Disease Control In ATLANTIC
16:45 - 18:00 | Presenter: Marina Chiara Garassino | Author(s): Byoung Chul Cho, Joo-Hang Kim, Julien Mazieres, Johan F. Vansteenkiste, Hervé Lena, Jesus Corral, Jhanelle Elaine Gray, John Powderly, Christos Chouaid, Paolo Bidoli, Paul Wheatley-Price, Keunchil Park, Ross Soo, Yifan Huang, Catherine Wadsworth, Phillip A. Dennis, Naiyer A Rizvi
- Abstract
Loading... -
+
P1.01-22 - Effect of Basal Lymphopenia on Outcome of Non Small Cell Lung Cancer Patients Treated with Immunotherapy
16:45 - 18:00 | Presenter: Giulia Galli | Author(s): Marta Poggi, Giovanni Fucà, Martina Imbimbo, Giuseppe Lo Russo, Claudia Proto, Diego Signorelli, Monica Ganzinelli, Nicoletta Zilembo, Filippo De Braud, Marina Chiara Garassino, Milena Vitali
- Abstract
Loading... -
+
P1.01-23 - High PD-L1 Expression is Less Common Than Expected Among Advanced NSCLC in Brazil. Are We Missing the Target?
16:45 - 18:00 | Presenter: Ana Caroline Zimmer Gelatti | Author(s): Vladmir Cláudio Cordeiro De Lima, Helano Freitas, Gustavo Werutsky, Ana Maria Gaiger, Clovis Klock, Patricia Pacheco Viola, Christina Shiang, Mariana Petaccia De Macedo, Lisandro Ferreira Lopes, Facundo Zaffaroni, Luiz H. Araujo, Eldsamira Mascarenhas, Clarissa Mathias, Fernando Moura, Giuliano Borges, Carlos Barrios, Mauro Zukin
- Abstract
Loading... -
+
P1.01-24 - Clinical Efficacy of Immunotherapy in Metastatic Non-Small Cell Lung Cancer Patients Treated with Prior Radiotherapy
16:45 - 18:00 | Presenter: Daniel Glick | Author(s): Elaine Wai, Mary Lesperance, Nicole Croteau, Edward Brooks, Dave Fenton, Leathia Fiorino, Georgia Geller, Zia Poonja, Doran Ksienski
- Abstract
Loading... -
+
P1.01-25 - Carboplatin and Pemetrexed Plus Bevacizumab After Failure of First-Line EGFR-TKI Therapy for NSCLC Harboring EGFR Mutation (CJLSG 0908)
16:45 - 18:00 | Presenter: Yasuhiro Goto | Author(s): Kosuke Takahashi, Hiroshi Saito, Tomohiko Ogasawara, Joe Shindoh, Tomoki Kimura, Yasuteru Sugino, Eiji Kojima, Fumio Nomura, Toru Nakanishi, Yasuhiro Nozaki, Yoshihiro Takeyama, Kazuyoshi Imaizumi, Yoshinori Hasegawa
- Abstract
Loading... -
+
P1.01-26 - Single-Centre Experience of Clinical Outcomes for Advanced Lung Cancer Patients in Phase I Clinical Trials.
16:45 - 18:00 | Presenter: Donna Marie Graham | Author(s): Thomas Jordan, Nadina Tinsley, Sreeja Aruketty, Alexander John Vickers, Claire Kelly, Roopa Kurup, Alison White, Amy Smith, Aisling Walsh, Chloe Thomson, Sinead O'Reilly, Michelle Norfolk, Dilshad Chang, Fiona Blackhall, Yvonne Summers, Raffaele Califano, Paul Taylor, Fiona Thistlethwaite, Natalie Cook, Louise Carter, Matthew G Krebs
- Abstract
Loading... -
+
P1.01-27 - Influence of EGFR-TKIs Treatment Lines and PFS on the Emergence of T790M Mutation
16:45 - 18:00 | Presenter: Xiaorong Dong | Author(s): Wanqiu Jia, Dejian Gu, Renhua Guo, Liyun Miao, Wenxian Wang, Chunwei Xu, Rongrong Chen, Xuefeng Xia
- Abstract
Loading... -
+
P1.01-28 - Impact of Afatinib Dosing on Safety and Efficacy Real-World in Patients with EGFR Mutation-Positive Advanced NSCLC
16:45 - 18:00 | Presenter: Balazs Halmos | Author(s): Eng-Huat Tan, Ross Soo, Jacques Cadranel, Min Ki Lee, Pascal Foucher, Te-Chun Hsia, Maximilian Johannes Hochmair, Frank Griesinger, Toyoaki Hida, Edward S Kim, Barbara Melosky, Angela Märten, Enric Carcereny
- Abstract
Loading... -
+
P1.01-29 - Crizotinib in Advanced Lung Adenocarcinoma Patients with ALK or ROS-1 Rearrangement: Is it the Same?
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Bo Zhang, Jianlin Xu, Yanwei Zhang, Xueyan Zhang, Tianqing Chu, Shuyuan Wang, Rong Qiao, Jie Qian, Jun Lu, Lele Zhang
- Abstract
Loading... -
+
P1.01-30 - Crizotinib in Advanced Non-Adenocarcinoma, NSCLC (NA-NSCLC) Patients with ALK Rearrangement: A Retrospective Study and Literature Review
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Bo Zhang, Yanwei Zhang, Jianlin Xu, Xueyan Zhang, Tianqing Chu, Shuyuan Wang, Jie Qian, Rong Qiao, Jun Lu, Lele Zhang
- Abstract
Loading... -
+
P1.01-31 - Weekly Regimen of PAXUS-PM, a Novel Cremophor-Free, with Carboplatin in Patients with Advanced Non-Small-Cell Lung Cancer in Vietnam
16:45 - 18:00 | Presenter: Mi-Ryung Jin | Author(s): Tuan Hang Quoc
- Abstract
Loading... -
+
P1.01-32 - A Multicenter, Open-Label, Phase II Trial of S-1 Plus Carboplatin in Advanced Non-Small Cell Lung Cancer Patients with Interstitial Lung Disease
16:45 - 18:00 | Presenter: Masaki Hanibuchi | Author(s): Soji Kakiuchi, Shinji Atagi, Fumitaka Ogushi, Eiji Shimizu, Takashi Haku, Yuko Toyoda, Masahiko Azuma, Mayo Kondo, Hiroshi Kawano, Kenji Otsuka, Satoshi Sakaguchi, Hiroshi Nokihara, Hisatsugu Goto, Yasuhiko Nishioka
- Abstract
Loading... -
+
P1.01-33 - Randomized Phase 2 Study Comparing CBDCA+PTX+BEV and CDDP+PEM+BEV in Treatment-Naïve Advanced Non-Sq NSCLC (CLEAR study)
16:45 - 18:00 | Presenter: Toshiyuki Harada | Author(s): Hibiki Udagawa, Eri Sugiyama, Shinji Atagi, Ryo Koyama, Satoshi Watanabe, Yukiko Nakamura, Daijiro Harada, Osamu Hataji, Fumihiro Tanaka, Akio Niimi, Hiroshi Kida, Miyako Satouchi, Akira Inoue, Yoshiko Urata, Yuki Yamane, Kiyotaka Yoh, Hiroshige Yoshioka, Takeharu Yamanaka, Koichi Goto
- Abstract
Loading... -
+
P1.01-34 - Docetaxel Plus Ramucirumab with Prophylactic PEG-G-CSF Support for Chemo-NaïVe Elderly NSCLC Patients: A Phase II Study (WJOG9416L)
16:45 - 18:00 | Presenter: Akito Hata | Author(s): Nobuyuki Katakami, Mototsugu Shimokawa, Shunichi Sugawara, Kazumi Nishino, Satoshi Hara, Hideyuki Nakagawa, Masamichi Mineshita, Motoko Tachihara, Koichi Azuma, Osamu Hataji, Hiroshi Tanaka, Toshiaki Takahashi, Toyoaki Hida, Akihiro Bessho, Eriko Tabata, Hiroshi Watanabe, Naoyuki Nogami, Toshihide Yokoyama, Hidetoshi Hayashi, Hiroaki Akamatsu, Isamu Okamoto, Tetsuya Mitsudomi, Nobuyuki Yamamoto, Kazuhiko Nakagawa
- Abstract
Loading... -
+
P1.01-35 - Tumor Volume Analysis In ALK-Rearranged NSCLC Treated with Crizotinib: Identifying an Early Marker for Clinical Outcome
16:45 - 18:00 | Presenter: Tomoyuki Hida | Author(s): Christine A Lydon, Hiroto Hatabu, Bruce E Johnson, Mark M. Awad, Mizuki Nishino
- Abstract
Loading... -
+
P1.01-36 - Thoracic Surgery in Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutant After Tyrosine Kinase Inhibitor Therapy
16:45 - 18:00 | Presenter: Chen-Hao Hsiao | Author(s): Shuenn-Wen Kuo, Ke-Cheng Chen, Jin-Shing Chen
- Abstract
Loading... -
+
P1.01-37 - BPI-9016M, a Novel c-Met Inhibitor, in Pretreated Advanced Solid Tumor: Results from a First-In-Human, Phase 1, Dose-Escalation Study
16:45 - 18:00 | Presenter: Xingsheng Hu | Author(s): Xin Zheng, Hongnan Mo, Xinhe Cui, Lieming Ding, Fenlai Tan, Pei Hu, Yuankai Shi
- Abstract
Loading... -
+
P1.01-38 - A Phase II With a Lead-In Phase I Study to Examine Safety and Efficacy of Hydroxychloroquine and Gefitinib in Advanced NSCLC
16:45 - 18:00 | Presenter: Yiqing Huang | Author(s): Alvin Wong, Ross Soo, Thomas Soh, Angela Pang, Chee Seng Tan, Winnie Ling, Pei Jye Voon, Joline Lim, Raghav Sundar, Nesaretnam Kumarakulasinghe, Hong Liang Lim, Boon Cher Goh, Tan Min Chin
- Abstract
Loading... -
+
P1.01-39 - Cost-Effectiveness of Crizotinib Versus Chemotherapy as First-Line Treatment of ALK Positive Advanced NSCLC -- A Real World Study
16:45 - 18:00 | Presenter: Meijuan Huang | Author(s): Yuke Tian, Mingmin He, Li Ren, Youling Gong, Feng Peng, Yongsheng Wang, Zhenyu Ding, Jin Wang, Jiang Zhu, Yong Xu, Yongmei Liu, Lanting Li, You Lu
- Abstract
Loading... -
+
P1.01-40 - Randomized Phase II Study of Docetaxel Plus Bevacizumab or Pemetrexed Plus Bevacizumab for Elderly pts with Untreated Advanced NSCLC: TORG1323
16:45 - 18:00 | Presenter: Kentaro Ito | Author(s): Osamu Hataji, Shigeru Tanzawa, Toshiyuki Harada, Nobukazu Fujimoto, Akihiro Bessho, Kei Takamura, Kazuhisa Takahashi, Tetsu Shinkai, Toshiyuki Kozuki, Miyako Satouchi, Terufumi Kato, Nobuhiko Seki, Takehito Shukuya, Natsumi Yamashita
- Abstract
Loading... -
+
P1.01-41 - A Phase 2 Study of DS-8201a in HER2-Overexpressing or -Mutated Advanced Non-Small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Pasi A Jänne | Author(s): Bob T. Li, Haruyasu Murakami, Ryota Shiga, Caleb C. Lee, Kongming Wang, David Planchard
- Abstract
Loading... -
+
P1.01-42 - Real-World Evaluation of Tolerability in Older Adult Patients (≥75 Years Old) with EGFR-mutated NSCLC
16:45 - 18:00 | Presenter: Shirley Xue Jiang | Author(s): Manjusha Hurry, Katrina Hueniken, Catherine Labbe, M Catherine Brown, Lawson Eng, Hiten Naik, Mindy Liang, Devalben Patel, Penelope Bradbury, Natasha B Leighl, Frances A Shepherd, Wei Xu, Geoffrey Liu, Ryan N. Walton, Grainne Mary O'Kane
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.01-44 - Outcome of Uncommon EGFR Mutation Positive Newly Diagnosed Advanced NSCLC Patients: A Single-Centre Retrospective Analysis
16:45 - 18:00 | Presenter: Shruti Kate | Author(s): Anuradha Choughule, Amit Joshi, Vanita Noronha, Vijay Patil, Rohit Dusane, Priyanka Tiwrekar, Leena Solanki, Vaishakhi Trivedi, Kumar Prabhash
- Abstract
Loading... -
+
P1.01-45 - Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey
16:45 - 18:00 | Presenter: Saadettin Kılıçkap | Author(s): Akın Ozturk, Nuri Karadurmuş, Taner Korkmaz, Perran Fulden Yumuk, İrfan Çiçin, Semra Paydaş, Ebru Çılbır, Teoman Sakalar, Mukremin Uysal, Necdet Üskent, Necla Demir, Abdullah Sakin, Nazim Serdar Turhal, Serkan Keskin, Deniz Tural, Yeşim Eralp, Fatma Basal, Hatime Arzu Yaşar, Mehmet Ali Nahit Sendur, Umut Demirci, Erdem Çubukçu, Mustafa Karaağaç, Şaziye Burçak Karaca, Ali Murat Tatlı, Tarkan Yetisyigit, Semiha Urvay, Pınar Gürsoy, Başak Oyan Uluç, Zeynep Hande Turna, Mehmet Kucukoner, Ömer Fatih Ölmez, Devrim Çabuk, Mehmet Metin Şeker, Olcun Umit Ünal, Nezih Meydan, Sadi Kerem Okutur, Didem Tunalı
- Abstract
Loading... -
+
P1.01-46 - Circulating Tumor DNA Analysis for Predicting Response to Osimertinib and Disease Progression in EGFR-Mutant Non-Small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Udayan Guha | Author(s): Chul Kim, Liqiang Xi, Constance M Cultraro, Trinh Hoc-Tran Pham, Nitin Roper, Mohammadhadi Bagheri, Arun Rajan, John Beeler, Greg Jones, Mark Raffeld
- Abstract
Loading... -
+
P1.01-47 - Phase I/II Trial of Dasatinib and Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
16:45 - 18:00 | Presenter: Chul Kim | Author(s): Stephen V Liu, Deepa S Subramaniam, Giuseppe Giaccone
- Abstract
Loading... -
+
P1.01-48 - Nab-Paclitaxel Plus Gemcitabine in Advanced NSCLC After Platinum-Based Chemotherapy: Final Results and Caveolin-1 Expression
16:45 - 18:00 | Presenter: Tatsunori Kiriu | Author(s): Motoko Tachihara, Akito Hata, Yukihisa Hatakeyama, Tatsuya Nagano, Masatsugu Yamamoto, Kazuyuki Kobayashi, Hisashi Ohnishi, Nobuyuki Katakami, Yoshihiro Nishimura
- Abstract
Loading... -
+
P1.01-49 - irAE, Possible Predictive Markers for Immune Checkpoint Inhibitors
16:45 - 18:00 | Presenter: Kazutoshi Komiya | Author(s): Tomomi Nakamura, Haruki Hirakawa, Shinsuke Ogusu, Chiho Nakashima, Koichiro Takahashi, Shinya Kimura, Naoko Sueoka-Aragane
- Abstract
Loading... -
+
P1.01-50 - Real World Experience of Nivolumab in Patients with Metastatic Nonsmall Cell Lung Cancer (mNSCLC)
16:45 - 18:00 | Presenter: Doran Ksienski | Author(s): Elaine Wai, Mary Lesperance, Nicole Croteau, Leathia Fiorino, Zia Poonja, Georgia Geller, Dave Fenton, Edward Brooks, Daniel Glick
- Abstract
Loading... -
+
P1.01-51 - Real world Experience of Pembrolizumab in Patients with Metastatic Nonsmall Cell Lung Cancer (mNSCLC)
16:45 - 18:00 | Presenter: Doran Ksienski | Author(s): Elaine Wai, Mary Lesperance, Nicole Croteau, Leathia Fiorino, Zia Poonja, Dave Fenton, Georgia Geller, Edward Brooks, Daniel Glick
- Abstract
Loading... -
+
P1.01-52 - BR-34- Randomized Trial of Durvalumab & Tremelimumab +/- Platinum Chemotherapy in Patients with Metastatic Squamous or Non-Squamous NSCLC
16:45 - 18:00 | Presenter: Swati Kulkarni | Author(s): Scott A. Laurie, Glenwood Goss, Francesco Perrone, Brett G.M Hughes, Nick Pavlakis, Martin R Stockler, Andre Blais, Labib Zibdawi, Francisco E. Vera - Badillo, Natasha B Leighl
- Abstract
Loading... -
+
P1.01-53 - Bone Metastases and Efficacy of Immunotherapy in Patients with Pretreated Advanced Non-Small-Cell Lung Cancer (NSCLC)
16:45 - 18:00 | Presenter: Lorenza Landi | Author(s): Federica D'Incà, Enrico Cortesi, Rita Chiari, Francesco Grossi, Angelo Delmonte, Filippo De Marinis, Diego Signorelli, Claudio Dazzi, Francesca Sperandi, Annamaria Catino, DIANA Giannarelli, Hector Josè Soto Parra, Gabriele Minuti, Paola Bordi, Maria Rita Migliorino, Antonio Palla, Giuseppe Tonini, Francesco Cognetti, Armando Santoro, Davide Tassinari, Alessandro Scoppola, Paolo Bidoli, Francovito Piantedosi, Michele Maio, Lucio Crinò, Federico Cappuzzo
- Abstract
Loading... -
+
P1.01-54 - A Phase I/Ib Study of Binimetinib (MEK162), a MEK Inhibitor Plus Carboplatin/Pemetrexed in Non-Squamous NSCLC
16:45 - 18:00 | Presenter: Natasha B Leighl | Author(s): Donna Graham, Eric Chen, Katherine Pisters, Penelope Bradbury, Mateya Trinkaus, Melissa Chan, Saroosh Arif, Urszula Zurawska, Jeffrey Rothenstein, Diane Zawisza, Stephanie Effendie, Maggie Sawczak
- Abstract
Loading... -
+
P1.01-55 - Unique Genetic Profiles from Cerebrospinal Fluid Could Predict Survival of EGFR-Mutant NSCLC with Leptomeningeal Metastases
16:45 - 18:00 | Presenter: Yangsi Li | Author(s): Ben-Yuan Jiang, Meimei Zheng, Hai-Yan Tu, Jin -Ji Yang, Xu-Chao Zhang, Jun-Yi Ye, Qing Zhou, Wen-Zhao Zhong, Chao Zhang, Shannon Chuai, Yi-Long Wu
- Abstract
Loading... -
+
P1.01-56 - Concurrent Mutations in Chinese Lung Cancer Patients Carrying HER2 Genomic Aberrations
16:45 - 18:00 | Presenter: Xuefeng Xia | Author(s): Jun Zhao, YUE Li, Xiaorong Dong, Xinghao Ai, Yu Chen, Gen Lin, Xiaotong Zhang, Wenxian Wang, Chunwei Xu, Rongrong Chen
- Abstract
Loading... -
+
P1.01-58 - Variants Distribution and Heterogeneity of Outcomes to Crizotinib in ALK-Rearranged Chinese Non-Small Cell Lung Cancers
16:45 - 18:00 | Presenter: Naixin Liang | Author(s): Puyuan Xing, Yudong Su, Xiang Long, Yang Gao, Peng Chen, Hao Liu, Tengfei Zhang, Bing Li, Lu Zhang, Xinru Mao, Zhe Zhang, Jing Liu
- Abstract
Loading... -
+
P1.01-59 - A Better Real World Practice for ROS1 Positive NSCLC Patients, Driven by the Targeted Next Generation Sequencing(NGS) and the Targeted TKI
16:45 - 18:00 | Presenter: Yongchang Zhang | Author(s): Zeng Liang, Nong Yang, yizhi Li
- Abstract
Loading... -
+
P1.01-60 - Preventing and Treating Brain Metastases with Three First-Line EGFR-TKI in Patients with EGFR Mutation Advanced NSCLC
16:45 - 18:00 | Presenter: Chien-Chung Lin | Author(s): Wu-Chou Su, Yi-Lin Wu
- Abstract
Loading... -
+
P1.01-61 - Clinical Characterization of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers
16:45 - 18:00 | Presenter: Zhefeng Liu | Author(s): Yi Hu, Lin Wu, Jun Cao, Zhe Yang, Cheng Zhi Zhou, Liming Cao, Hao Wu, Haibo Shen, Meiling Jin, Yong Zhang, Xinru Mao, Jianxing Xiang, Ke Ma, Bing Li, Tengfei Zhang
- Abstract
Loading... -
+
P1.01-62 - The Third Generation Irreversible EGFR Inhibitor HS-10296 in Advanced Non-Small Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Shun Lu | Author(s): Ross Camidge, Cheng-Ta Yang, Jianying Zhou, Renhua Guo, Chao-Hua Chiu, Gee-Chen Chang, Her-Shyong Shiah, Yan Chen, Chin-Chou Wang, David Berz, Wu-Chou Su, Nong Yang, Ziping Wang, Jian Fang, Jianhua Chen, Petros Nikolinakos, You Lu, Hongming Pan, Ajit Maniam, Lyudmila A Bazhenova, Keisuke Shirai, Mohammad Jahanzeb, Maurice Willis, Nehal Masood, Naveed Chowhan, Te-Chun Hsia, James Chih-Hsin Yang
- Abstract
Loading... -
+
P1.01-63 - Correlation Between Immune-Related Adverse Events and Efficacy of Immune-Checkpoint Inhibitors in Patients with Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Margarita Majem Tarruella | Author(s): Mariona Riudavets Melià, Ivana Gabriela Sullivan, Andrés Barba Joaquín, Geòrgia Anguera Palacios, Luís Del Carpio Huerta, Consolació Moltó Valiente, Silvia Daniela Camacho Arellano, Sara Moron Asensio, Paula Gomila Pons, Marta Andrés Granyó, Diego Castillo Villegas, Carme Facundo Molas, Esther Garcia Planella, Cintia González Blanco, Idoia Genua Trullos, Laura Tuneu Valls, Nicole Stantonyonge Sesnic, Agustí Barnadas Molins, Ignasi Gich Saladich
- Abstract
Loading... -
+
P1.01-64 - Impact of STK11 Co-Mutation on Outcomes Following Immunotherapy Among Patients with TP53 and KRAS Mutated Stage IV NSCLC
16:45 - 18:00 | Presenter: Melina Elpi Marmarelis | Author(s): Erin Bange, Stephen Bagley, Wei-Ting Hwang, Yu-Xiao Yang, Jeffrey C Thompson, Joshua Michael Bauml, Christine Ciunci, Evan Alley, Jennifer Morrissette, Roger B Cohen, Corey J Langer, Erica Carpenter, Charu Aggarwal
- Abstract
Loading... -
+
P1.01-65 - PII of Pemetrexed or Pemetrexed Plus Bevacizumab for Previously Untreated Elderly (>=75) Non-Squamous NSCLC (LOGIK1201)
16:45 - 18:00 | Presenter: RIICHIRO Maruyama | Author(s): Minoru Fukuda, Takeshi Kitazaki, Daiki Ogawara, Masao Ichiki, Hiroshi Mukae, Noriaki Nakagaki, Junji Kishimoto, Yukito Ichinose, Kenji Sugio
- Abstract
Loading... -
+
P1.01-66 - Randomized Phase II Evaluating EGFR-TKI Associated with Anti-Estrogen in Women with Non-Squamous Advanced Stage NSCLC: IFCT-1003 LADIE Trial.
16:45 - 18:00 | Presenter: Julien Mazieres | Author(s): Fabrice Barlesi, Isabelle Rouquette, Benjamin Besse, Isabelle Monnet, Clarisse Audigier-Valette, Anne Claire Toffart, Aldo Renault, Severine Moreau, Sandrine Hiret, Bertrand Mennecier, Didier Debieuvre, Virginie Westeel, Philippe Masson, Anne Madroszyk, Elodie Amour, Franck Morin, Gerard Zalcman, Denis Moro-Sibilot, Pierre Jean Souquet
- Abstract
Loading... -
+
P1.01-67 - Clinical Relevance of ALK/ROS1 Resistance Mutations and Other Acquired Mutations Detected by Liquid Biopsy in Advanced NSCLC Patients
16:45 - 18:00 | Presenter: Laura Mezquita | Author(s): Aurélie Swalduz, Cecile Jovelet, Sandra Ortiz-Cuaran, David Planchard, Virginie Avrillon, Gonzalo Recondo, Solène Marteau, Vincent Plagnol, Karen Howarth, Clive Morris, Emma Green, Ludovic Lacroix, Luc Odier, Etienne Rouleau, Pierre Fournel, Caroline Caramella, Claire Tissot, Julien Adam, Maurice Pérol, Luc Friboulet, Pierre Saintigny, Benjamin Besse
- Abstract
Loading... -
+
P1.01-68 - Correlation of the Lung Immune Prognostic Index (LIPI) and PDL1 Status with Outcomes for Immune Checkpoint Inhibitors in Advanced NSCLC Patients
16:45 - 18:00 | Presenter: Laura Mezquita | Author(s): Wungki Park, Kathryn C Arbour, Edouard Auclin, Lizza Hendriks, David Planchard, Diana Saravia, Santiago Ponce Aix, Ernest Nadal, Clarisse Audigier-Valette, Simona Carnio, Julien Adam, José Carlos Ruffinelli, Gerard Zalcman, Gianmauro Numico, Ivana Sullivan, Luis Paz-Ares, Anne-Marie C. Dingemans, Silvia Novello, Matthew D. Hellmann, Gilberto de Lima Lopes, Benjamin Besse
- Abstract
Loading... -
+
P1.01-69 - Validation of the Lung Immune Prognostic Index (LIPI): Useful to Identify Resistance to PD-1 Checkpoint Inhibitors in Pretreated Lung Cancer
16:45 - 18:00 | Presenter: Xabier Mielgo-Rubio | Author(s): María Sereno Moyano, Miguel Jhonatan Sotelo-Lezama, Rafael Lopez Castro, Judit Rubio-Martínez, Alejandro Velastegui, Clara Olier-Garate, Sandra Falagan, Isabel Gómez-Barreda, Alejandro Riquelme, Ana Cardeña-Gutiérrez, Juan Moreno Rubio, Cynthia López, Coralia Bueno, Jorge Silva-Ruiz, Estefanía Zhan Zhou, Luis Enrique Chara
- Abstract
Loading... -
+
P1.01-70 - Efficacy and Safety of Second- or Third-Line Nab-Paclitaxel + Durvalumab in Patients with Advanced NSCLC (ABOUND.2L+)
16:45 - 18:00 | Presenter: Daniel Morgensztern | Author(s): Ramaswamy Govindan, Manuel Cobo, Santiago Ponce Aix, Pieter E. Postmus, Conrad Lewanski, Jaafar Bennouna, Juergen R. Fischer, Óscar Juan-Vidal, David J Stewart, Andrea Ardizzoni, Rafia Bhore, Marianne Wolfsteiner, Martin Reck, Denis Talbot, Teng Jin Ong
- Abstract
Loading... -
+
P1.01-71 - Co-Mutations, Natural History, and Outcomes of BRAF-Mutated Non-Small Cell Lung Cancer at a Single Academic Cancer Center
16:45 - 18:00 | Presenter: Nathaniel James Myall | Author(s): Solomon Henry, Douglas Wood, Joel W. Neal, Heather A Wakelee
- Abstract
Loading... -
+
P1.01-72 - FIND Trial: A Phase II Study to Evaluate the Efficacy of the FGFR-Inhibitor Erdafitinib in FGFR-Mutated and -Translocated Squamous NSCLC
16:45 - 18:00 | Presenter: Jürgen Wolf | Author(s): Lucia Nogova, Florian Malchers, Gregor Zadoyan, Axel Hillmer, Sabine Merkelbach-Bruse, Richard Riedel, Sebastian Michels, Behzad Kharabi Masouleh, Peter De Porre, Ademi Santiago-Walker, Matthias Scheffler, Rieke N Fischer, Diana Abdulla, Roman Thomas, Reinhard Büttner
- Abstract
Loading... -
+
P1.01-73 - Preliminary Results of the SENECA (SEcond Line NintEdanib in Non-Small Cell Lung CAncer) Trial: An Italian Experience.
16:45 - 18:00 | Presenter: Silvia Novello | Author(s): Enrica Capelletto, Maria Rita Migliorino, Alessandro Morabito, Rita Chiari, Francesco Grossi, Marcello Tiseo, Francesco Di Costanzo, Angelo Delmonte, Gianpiero Romano, Andrea Misino, Vieri Scotti, Vanesa Gregorc, Salvatore Pisconti, Giovanni L Ceresoli, Alessandro Del Conte, Libero Ciuffreda, Ida Colantonio, Emilio Bria, Serena Ricciardi, Anna Manzo, Giulio Metro, Anna Maira Morelli, Rossana Critelli, Ilaria Stura, Giuseppe Migliaretti
- Abstract
Loading... -
+
P1.01-74 - MET Exon 14-Altered Lung Cancers: Central Nervous System (CNS) Metastases and Patterns of CNS Progression on MET Inhibition.
16:45 - 18:00 | Presenter: Michael Offin | Author(s): Jordan Dienstag, Olivia Wilkins, Joshua K Sabari, Ai Ni, Daniel L. Feldman, Martine Van Voorthuysen, Ken Suzawa, Helena Yu, Gregory J Riely, Maria E Arcila, Marc Ladanyi, Mark G Kris, Charles M. Rudin, Romel Somwar, Bob T. Li, Alexander Drilon
- Abstract
Loading... -
+
P1.01-75 - Utility of cfDNA Testing for Acquired Resistance: The Memorial Sloan Kettering Experience with Plasma EGFR T790M Clinical Testing.
16:45 - 18:00 | Presenter: Michael Offin | Author(s): Mackenzie Myers, Sowmya Josyula, Ronglai Shen, Laetitia Borsu, Dana Tsui, Gregory J Riely, Charles M. Rudin, Helena Yu, Bob T. Li, Maria E Arcila
- Abstract
Loading... -
+
P1.01-76 - A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers
16:45 - 18:00 | Presenter: Paul K. Paik | Author(s): Rachel Kim, Linda Ahn, Andrew Plodkowski, Kenneth Ng, Daniel McFarland, Afsheen Iqbal, Juliana Eng, Charles M. Rudin
- Abstract
Loading... -
+
P1.01-77 - Osimertinib in the First-Line Treatment of Non-Small Cell Lung Cancer Harboring Activating EGFR Mutation from Circulating Tumor DNA
16:45 - 18:00 | Presenter: Cheol-Kyu Park | Author(s): Hyun-Ju Cho, Yoo Duk Choi, In-Jae Oh, Young-Chul Kim
- Abstract
Loading... -
+
P1.01-78 - The Incidence of Brain Metastases in ROS1-Rearranged Non-Small Cell Lung Cancer at Diagnosis and Following Progression on Crizotinib
16:45 - 18:00 | Presenter: Tejas Patil | Author(s): Derek E Smith, Paul A. Bunn, Jr., Dara L. Aisner, Anh T Le, Mark Hancock, William T Purcell, Daniel W Bowles, Ross Camidge, Robert C. Doebele
- Abstract
Loading... -
+
P1.01-79 - CheckMate 817: Safety of Flat-Dose Nivolumab Plus Weight-Based Ipilimumab for the First-line (1L) Treatment of Advanced NSCLC
16:45 - 18:00 | Presenter: Luis Paz-Ares | Author(s): Laszlo Urban, Clarisse Audigier-Valette, Francesco Grossi, Kevin Jao, Jean-Sebastien Aucoin, Helena Linardou, Elena Vladimirovna Poddubskaya, Juergen R. Fischer, Alessandra Curioni Fontecedro, Harry J.M. Groen, Karim Vermaelen, Maryam Bourhaba, Dariusz Kowalski, Rathi N Pillai, David R. Spigel, Samreen Ahmed, Wenhua Hu, Donna Vickery, Joseph Fiore, Neal E. Ready
- Abstract
Loading... -
+
P1.01-80 - ELIOS: A Multicenter, Open-Label, Molecular Profiling Study of Patients with EGFRm and NSCLC Treated with Osimertinib
16:45 - 18:00 | Presenter: Zofia Piotrowska | Author(s): Juliann Chmielecki, Diana Cripps, Miguel F Miranda
- Abstract
Loading... -
+
P1.01-81 - Phase 3 Study of Pemetrexed-Platinum with or without Pembrolizumab for TKI-Resistant/EGFR-Mutated Advanced NSCLC: KEYNOTE-789
16:45 - 18:00 | Presenter: Gregory J Riely | Author(s): Rina Hui, David P Carbone, Keunchil Park, Marion Carrigan, Xia Xu, Thao Dang, James Chih-Hsin Yang
- Abstract
Loading... -
+
P1.01-82 - Risk of Not Receiving 2nd Line Therapy is High in EGFR mt+ pts: Real World Data of Certified Lung Cancer Centers on Treatment Sequence in EGFR mt+ pts
16:45 - 18:00 | Presenter: Julia Roeper | Author(s): Markus Falk, Stefanie Schatz, Markus Tiemann, Sandra Sackmann, Dieter Ukena, Claas Wesseler, Gunther Wiest, Lukas Heukamp, Frank Griesinger
- Abstract
Loading... -
+
P1.01-83 - IMpower150: Impact of Chemotherapy Cycles in 1L Metastatic NSCLC in Patients Treated With Atezolizumab + Bevacizumab
16:45 - 18:00 | Presenter: Jeffrey Rothenstein | Author(s): Alexander Spira, Vamsidhar Velcheti, Ronald B Natale, Mark F Kozloff, Michael Kosty, Jerome Goldschmidt Jr., Julien Mazieres, Santiago Ponce Aix, Wei Yu, Mayank Gandhi, Anthony Lee, Geetha Shankar, Wei Lin, Christian A. Thomas
- Abstract
Loading... -
+
P1.01-84 - High Basal Serum EGF Levels Predicts Response to CIMAvax-EGF, a Therapeutic Vaccine for Advanced NSCLC
16:45 - 18:00 | Presenter: Orestes Santos Morales | Author(s): Patricia Luaces, Tania Crombet, Camilo Rodríguez, Elia Neninger
- Abstract
Loading... -
+
P1.01-85 - The Prevalence of Different EGFR exon20 Mutations in 12,833 Chinese Lung Cancer Patients
16:45 - 18:00 | Presenter: Yang W. Shao | Author(s): Xiaoling Tong, Xiaonan Wang, Fufeng Wang, Xue Wu
- Abstract
Loading... -
+
P1.01-86 - BTCRC-LUN15-017: Phase-Ib Study of Imprime PGG and Pembrolizumab in Stage IV NSCLC after Progression on Platinum Based Therapy
16:45 - 18:00 | Presenter: Ardaman Shergill | Author(s): Muhammad Furqan, Jyoti Malhotra, Li Liu, Nandita Bose, Chandra Belani, Lawrence Eric Feldman
- Abstract
Loading... -
+
P1.01-87 - A Phase 1b Study of TRC105 In Combination with Paclitaxel/Carboplatin and Bevacizumab in Patients with Stage 4 Non-Squamous Cell Lung Cancer
16:45 - 18:00 | Presenter: Garrett Sherwood | Author(s): Francisco Robert, Mary Jerome, Debi Miley, Michael Harris, Brian Simpson, Bonne Adams, Charles Theuer
- Abstract
Loading... -
+
P1.01-88 - Osimertinib Maintenance After Definitive Chemoradiation in Patients with Unresectable EGFRm-Positive Stage III NSCLC (LAURA)
16:45 - 18:00 | Presenter: Lu Shun | Author(s): Tony Nash, Matilde Saggese, Helen Mann, Suresh S. Ramalingam
- Abstract
Loading... -
+
P1.01-89 - Analysis and Monitoring CTCs and ctDNA in CSF Demonstrates Clinical Concordance in Tesevatinib Treated NSCLC Patients with LM
16:45 - 18:00 | Presenter: Veena M. Singh | Author(s): Cecile Rose T Vibat, Masha V. Poyurovsky, Laurie S. Green, Beth Mac Gillivray, David A. Eiznhamer
- Abstract
Loading... -
+
P1.01-90 - A Pilot Trial Assessing Apatinib Combined with Docetaxel (DTX) as Second-Line Chemotherapy for EGFR Negative Advanced NSCLC)
16:45 - 18:00 | Presenter: Yong Song | Author(s): Tang Feng Lv, Hongbing Liu, Liyun Miao, Zhaoxia Wang, Meiqi Shi
- Abstract
Loading... -
+
P1.01-91 - A Phase I Study of Fixed Dose Vinorelbine and Escalating Doses of Ifosfamide in First-Line Advanced Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Julian Surujballi | Author(s): Daniel Breadner, Donald Morris, Anne O'Connor, Frances Whiston, Larry Sitt, Mark David Vincent
- Abstract
Loading... -
+
P1.01-92 - A Phase II Study of Afatinib Treatment for Elderly Patients with Previously Untreated Advanced NSCLC Harboring EGFR Mutations
16:45 - 18:00 | Presenter: Kensuke Suzuki | Author(s): Hisao Imai, Kyoichi Kaira, Masaki Anzai, Takeshi Tsuda, Tamotsu Ishizuka, Tomohito Kuwako, Ichiro Naruse, Kenji Nemoto, Junji Uchino, Nobutoshi Morozumi, Shinichi Ishihara, Koichi Minato, Takeshi Hisada
- Abstract
Loading... -
+
P1.01-93 - Quality of Life in Patients with Advanced NSCLC Treated in Second- or Third-Line with Nab-Paclitaxel + Durvalumab: ABOUND.2L+
16:45 - 18:00 | Presenter: Santiago Ponce Aix | Author(s): Denis Talbot, Ramaswamy Govindan, Manuel Cobo, Pieter E. Postmus, Conrad Lewanski, Jaafar Bennouna, Juergen R. Fischer, Óscar Juan-Vidal, David J Stewart, Andrea Ardizzoni, Rafia Bhore, Marianne Wolfsteiner, Martin Reck, Daniel Morgensztern, Teng Jin Ong
- Abstract
Loading... -
+
P1.01-94 - Phase I Trial to Establish Maximum Tolerated Dose Safety and Pharmacokinetic Profile of Oral Paclitaxel
16:45 - 18:00 | Presenter: Satheesh Chiradoni Thungappa | Author(s): Rashmi Nulenur Rajappa, Immadi Sreevallika,, Shirish Sadashiv Alurkar, Sanjay Patel, Bakulesh Khamar Khamar
- Abstract
Loading... -
+
P1.01-95 - Crizotinib Treatment in 29 Advanced NSCLC Chinese Patients with ROS1 Rearrangement——A Single Chinese Cancer Institute Experience
16:45 - 18:00 | Presenter: Jialei Wang | Author(s): Chang Liu, Jianhua Chang, Weixin Zhao, Hui Yu, Zhengfei Zhu, Si Sun, Min Fan
- Abstract
Loading... -
+
P1.01-96 - Concurrent ALK/EGFR Alterations in Chinese Lung Cancers: Frequency, Clinical Features, and Differential Response to Therapy
16:45 - 18:00 | Presenter: Da Wu | Author(s): Jixian Liu, Zhimin Mu, Li Liu, Kang Li, Richeng Jiang, Peng Chen, Qiang Zhou, Meiling Jin, Yuxiang Ma, Yuancai Xie, Jianxing Xiang, Tengfei Zhang, Bing Li, Bing Yu
- Abstract
Loading... -
+
P1.01-97 - Cluster Trial: Ph2 Biomarker-Integrated Study of Single Agent Alpelisib, Capmatinib, Ceritinib and Binimetinib in advNSCLC
16:45 - 18:00 | Presenter: Yi-Long Wu | Author(s): Qing Zhou, Xu-Chao Zhang, Hai-Yan Tu, Bin Gan, Bin-Chao Wang, Chong-Rui Xu, Hua-Jun Chen, Ming-ying Zheng, Zhen Wang, Xiao-Yan Bai, Yue-Li Sun, Andrea Myers, Xueting Lv, Yajnaseni Chakraborti, Sylvia Zhao, Jin -Ji Yang
- Abstract
Loading... -
+
P1.01-98 - A Phase IIIb Trial of Afatinib in EGFRm+ NSCLC: Analyses of Outcomes in Patients with Brain Metastases or Dose Reductions
16:45 - 18:00 | Presenter: Yi-Long Wu | Author(s): Haiyan Tu, Jifeng Feng, Meiqi Shi, Jun Zhao, Yuyan Wang, Jianhua Chang, Jialei Wang, Ying Cheng, Jing Zhu, Eng-Huat Tan, Kai Li, Yi Ping Zhang, Victor Lee, Cheng-Ta Yang, Wu-Chou Su, David Chi-Leung Lam, BJ Srinivasa, Senthil Rajappa, Ching-Liang Ho, Kwok Chi Lam, Yi Hu, Shailesh Arjun Bondarde, Xiaoqing Liu, Dennis Chin-Lun Huang, Yu Wang, Kaimin Pang, Caicun Zhou
- Abstract
Loading... -
+
P1.01-99 - Detecting HER2 Alterations by Next Generation Sequencing (NGS) in Patients with Advanced NSCLC from the United States and China
16:45 - 18:00 | Presenter: Chong-Rui Xu | Author(s): Yi-Chen Zhang, Dazhi Liu, Ronglai Shen, Pedram Razavi, Si-Yang Liu, Hao Sun, Michael Offin, Alexander Drilon, Charles M. Rudin, Maria E Arcila, Yi-Long Wu, Bob T. Li
- Abstract
Loading...
-
+
P1.02 - Advocacy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.02-01 - Imaging of Lung Cancer at the University College Hospital, Ibadan, Nigeria: Does Nuclear Medicine Have Anything to Offer?
16:45 - 18:00 | Presenter: Olusegun Akinwale Ayeni | Author(s): Akintunde Taiwo Orunmuyi
- Abstract
Loading... -
+
P1.02-02 - ‘Listen To Your Lungs’ – An Awareness Campaign from The Marie Keating Foundation
16:45 - 18:00 | Presenter: Anne-Marie Baird | Author(s): Liz Yeates
- Abstract
Loading... -
+
P1.02-03 - The Role of Lung Cancer Advocacy Organizations in Biomarker Testing
16:45 - 18:00 | Presenter: Winfield Boerckel | Author(s): Carolyn Aldige, Upal Basu Roy, Andrew Ciupek, Dusty Donaldson, Hildy Grossman, Cindy Langhorne, Lauren S. Rosenthal, Claire Saxton, Gerard A. Silvestri, Robert A. Smith, Linda Wenger
- Abstract
Loading... -
+
P1.02-04 - The EGFR Resisters Lung Cancer Group: A Patient-Driven Initiative to Understand & Improve Treatments for EGFR+ Lung Cancer
16:45 - 18:00 | Presenter: Jill Feldman | Author(s): Ivy Elkins
- Abstract
Loading... -
+
P1.02-05 - ALK Positive Lung Cancer: Patient Engagement and Partnership
16:45 - 18:00 | Presenter: Shelly Engfer-Triebenbach | Author(s): Laura Greco
- Abstract
Loading... -
+
P1.02-06 - Usefulness of Workshop to Promote Communication Between Patient and Family
16:45 - 18:00 | Presenter: Kazuo Hasegawa
- Abstract
Loading... -
+
P1.02-07 - The Role of Volunteers in Quality Palliative Care Delivery for Advance Lung Cancer
16:45 - 18:00 | Presenter: Aditya Manna
- Abstract
Loading... -
+
P1.02-08 - Hope for People Living with Metastatic Lung Cancer
16:45 - 18:00 | Presenter: Aditya Manna
- Abstract
Loading... -
+
P1.02-09 - Identifying Gaps in Messaging for Biomarker Testing in the Lung Cancer Community: Need for Consistent and Actionable Messaging
16:45 - 18:00 | Presenter: Upal Basu Roy | Author(s): Margery Jacobson, Andrea Ferris, Kayla Haskins
- Abstract
Loading... -
+
P1.02-10 - "We Are Ambassadors for Survivors:" Experiences of Lung Cancer Support Group Attendees and Facilitators
16:45 - 18:00 | Presenter: Maureen Rigney | Author(s): Kerri Susko, Tamara Church, Joanne S Buzaglo
- Abstract
Loading... -
+
P1.02-11 - Lung Cancer Symptom Awareness: Findings from a Global Consumer Survey
16:45 - 18:00 | Presenter: Maureen Rigney | Author(s): Aoife McNamara, Jesme Fox, Greg Manuel, Sarah Winstone
- Abstract
Loading...
-
+
P1.03 - Biology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.03-01 - Association of APC Mutations with Chinese Patients Molecular Spectrum in Non-Small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Shuitu Feng | Author(s): Chunwei Xu, Wenxian Wang, Quxia Zhang, Wu Zhuang, Youcai Zhu, Yunjian Huang, Yanping Chen, Gang Chen, Meiyu Fang, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-02 - Analysis of SMAD4 Aberrations in Chinese Patients with Non-Small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Jianhui Huang | Author(s): Chunwei Xu, Wenxian Wang, Quxia Zhang, Yuefeng Zhou, Wu Zhuang, Youcai Zhu, Zhangzhou Huang, Yanping Chen, Gang Chen, Meiyu Fang, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-03 - Molecular Characteristics of Chinese Patients with TSC2-Mutated Non-Small-Cell Lung Cancer: A Retrospective Study
16:45 - 18:00 | Presenter: Zhangzhou Huang | Author(s): Chunwei Xu, Wenxian Wang, Quxia Zhang, Wu Zhuang, Youcai Zhu, Yanping Chen, Gang Chen, Meiyu Fang, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-04 - Molecular Characteristics of ALK Primary Point Mutations Non-Small-Cell Lung Cancer in Chinese Patients
16:45 - 18:00 | Presenter: Chunwei Xu | Author(s): Jinhuo Lai, Wenxian Wang, Quxia Zhang, Wu Zhuang, Yunjian Huang, Youcai Zhu, Yanping Chen, Gang Chen, Meiyu Fang, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-05 - Transcriptome Landscape of Lung Adenocarcinoma Patients Revealed Distinct Trajectory Patterns
16:45 - 18:00 | Presenter: Yuqing Lou | Author(s): Yanwei Zhang, Jianlin Xu, Wei Zhang, Xueyan Zhang, Rong Li, Baohui Han
- Abstract
Loading... -
+
P1.03-06 - Molecular Landscape of FGFR1 Point Mutations in Chinese Non-Small-Cell Lung Cancer Patients: A Retrospective Study
16:45 - 18:00 | Presenter: Quxia Zhang | Author(s): Hong Wang, Chunwei Xu, Wenxian Wang, Wu Zhuang, Youcai Zhu, Yunjian Huang, Yanping Chen, Gang Chen, Meiyu Fang, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-07 - A Comparison of Consistency of Detecting HER2 Gene Mutations in Peripheral Blood and Tumor Tissue of Non-Small-Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Chunwei Xu | Author(s): Wenxian Wang, Quxia Zhang, Youcai Zhu, Wu Zhuang, Yunjian Huang, Yanping Chen, Gang Chen, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-08 - Detection of PTCH1 Gene Variants in Non-Small Cell Lung Cancer Patients from China
16:45 - 18:00 | Presenter: Quxia Zhang | Author(s): Tianwen Xu, Chunwei Xu, Wenxian Wang, Wu Zhuang, Youcai Zhu, Zhangzhou Huang, Yanping Chen, Gang Chen, Meiyu Fang, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-09 - ROS1 Rearrangement in Pulmonary Sarcomatoid Carcinoma: A Retrospective Study of the Real World
16:45 - 18:00 | Presenter: Chunwei Xu | Author(s): Wenxian Wang, Youcai Zhu, Meiyu Fang, Wu Zhuang, Quxia Zhang, Yanping Chen, Ziying Gong, Gang Chen, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-10 - The Molecular Spectrum of NF1 Variants in Chinese Non-Small-Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Quxia Zhang | Author(s): Chunwei Xu, Wenxian Wang, Wu Zhuang, Youcai Zhu, Zhangzhou Huang, Yanping Chen, Gang Chen, Meiyu Fang, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-11 - Analysis of T-Cell Repertoires in Benign and Malignant Solitary Pulmonary Nodules to Evaluate Tumor Immune Microenviroment
16:45 - 18:00 | Presenter: Min Li | Author(s): Shichao Deng, Shiqing Liu, Bingrong Zhao, Jian An, Pengbo Deng, Liming Cao, Huaping Yang, Qihua Gu, Huaibo Sun, Yuqi Wang, Yanfang Guan, Xuefeng Xia, Xin Yi, Chengping Hu
- Abstract
Loading... -
+
P1.03-12 - PD-L1 Expression is Predominant in CD68+ Tumor-Associated Macrophages in Stage I-III Non-Small Cell Lung Cancers
16:45 - 18:00 | Presenter: Boris Sepesi | Author(s): Lorenzo Federico, Kyle Gregory Mitchell, Edwin Parra, Alejandro Francisco Cruz, Andrea Ravelli, Cara Haymaker, Tatiana Karpinets, Tina Cascone, Annikka Weissferdt, Mara B Antonoff, Garrett L Walsh, Chantale Bernatchez, Jack A Roth, Jianjun Zhang, Emily Roarty, Lara Carolina Alvarez de Lacerda Landry, Ara A Vaporciyan, Stephen Swisher, John V Heymach, Ignacio I. Wistuba, Don Lynn Gibbons
- Abstract
Loading... -
+
P1.03-13 - eIF2β, A Subunit of Translation-Initiation Factor EIF2, as a Potential Therapeutic Target for Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Daiki Goto | Author(s): Ichidai Tanaka, Mitsuo Sato, Toshio Kato, Ayako Miyazawa, Tetsunari Hase, Masahiro Morise, Yoshitaka Sekido, Luc Girard, John D Minna, Lauren Byers, John V Heymach, Kevin R Coombes, Masashi Kondo, Yoshinori Hasegawa
- Abstract
Loading... -
+
P1.03-14 - Interaction Between Celecoxib and Cisplatin is Dependent on The p53 Status in Human NSCLC Cell Lines
16:45 - 18:00 | Presenter: Weiying Li | Author(s): Mei Jiang, Li Ma, Lina Zhang, Jinjing Tan, Suhua Zheng, Yang Liu
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.03-16 - Anlotinib Inhibits Angiogenesis of Refractory Advanced Non-Small Cell Lung Cancer via Blocking CCL2 Expression
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Jun Lu, Hua Zhong, Tianqing Chu, Xueyan Zhang, Rong Li, Jiayuan Sun, Runbo Zhong, Yuqing Yang, Mohammad Shah Alam, Yuqing Lou, Jianlin Xu, Yanwei Zhang, Jun Wu, Xiaowei Li, Xiaodong Zhao, Kai Li, Liming Lu
- Abstract
Loading... -
+
P1.03-17 - Functional Mechanism of GLDC Gene Alternative Splicing in Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Kewei Ma | Author(s): Yingli Yuan
- Abstract
Loading... -
+
P1.03-18 - Mechanobiology of Lung Cancer Cells: Regulation of PD-L1 Expression by Matrix Stiffness
16:45 - 18:00 | Presenter: Ayako Miyazawa | Author(s): Satoru Ito, Shuichi Asano, Ichidai Tanaka, Mitsuo Sato, Masashi Kondo, Yoshinori Hasegawa
- Abstract
Loading... -
+
P1.03-19 - Antibody Blockade of Integrin Alpha-V-Beta-6 (avb6) as a Novel Treatment for NSCLC
16:45 - 18:00 | Presenter: Banu Rudran | Author(s): Claire Susannah Reader, Julie Foster, Kairbaan Hodivala-Dilke, Jane Sosabowski, John Frances Marshall
- Abstract
Loading... -
+
P1.03-20 - The Novel SFN Inhibitors Aprepitant and Ticagrelor Exert Anti-Tumor Effects Through Blocking of Oncoprotein Ubiquitination
16:45 - 18:00 | Presenter: Aya Shiba | Author(s): JeongMin Hong, Takatsugu Hirokawa, YunJung Kim, Masayuki Noguchi
- Abstract
Loading... -
+
P1.03-21 - Huaier Aqueous Extract Induces Lung Adenocarcinoma Cell Apoptosis Through Excessive Activation Of MEK/ERK Signaling Pathway
16:45 - 18:00 | Presenter: Zhao Shilei | Author(s): Chundong Gu, Lei Zhao, Fachen Zhou, Jin Wang
- Abstract
Loading... -
+
P1.03-22 - MiR-125b Plays a Tumor Suppressor Role in Inflammation-Related Non-Small Cell Lung Cancer via Repressing IGF-1 Signal Pathway
16:45 - 18:00 | Presenter: Yanwei Zhang | Author(s): Yuqing Lou, Beibei Sun, Xueyan Zhang, Baohui Han
- Abstract
Loading... -
+
P1.03-23 - The Molecular Landscape and Outcome of Chinese Patients with Non-Small Cell Lung Cancer Harboring NTRK1 Point Mutations: A Retrospective Study
16:45 - 18:00 | Presenter: Xiaohui Chen | Author(s): Chunwei Xu, Wenxian Wang, Quxia Zhang, Wu Zhuang, Youcai Zhu, Yanping Chen, Meiyu Fang, Gang Chen, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-24 - TMPRSS4: A Novel Prognostic Biomarker and Therapeutic Target in NSCLC
16:45 - 18:00 | Presenter: Francisco Expósito | Author(s): María Villalba, María José Pajares, Miriam Redrado, Cristina Sainz, Ignacio I. Wistuba, Carmen Behrens, Esther Redin, Carlos Andrea, Cristina Cirauquiz, Luis M Montuenga, Ruben Pio, Alfonso Calvo
- Abstract
Loading... -
+
P1.03-25 - The Frequency and Prognosis of ATM Mutations in Chinese Non-Small-Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Quxia Zhang | Author(s): Chuanjun Han, Chunwei Xu, Wenxian Wang, Wu Zhuang, Youcai Zhu, Yunjian Huang, Yanping Chen, Gang Chen, Meiyu Fang, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-26 - Analysis of DDR2 Gene Aberrations in Chinese Non-Small-Cell Lung Cancer Patients and Evaluation of Their Prognosis
16:45 - 18:00 | Presenter: Chunwei Xu | Author(s): Jinhuo Lai, Wenxian Wang, Quxia Zhang, Wu Zhuang, Youcai Zhu, Zhangzhou Huang, Yanping Chen, Gang Chen, Meiyu Fang, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-27 - Somatic Mutations in BRCA2 Genes Are Associated with Prognosis in Chinese Non-Small-Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Chunwei Xu | Author(s): Jinhuo Lai, Wenxian Wang, Quxia Zhang, Wu Zhuang, Youcai Zhu, Yunjian Huang, Yanping Chen, Gang Chen, Meiyu Fang, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-28 - Association Between Molecular Characteristics of CTNNB1 Mutations and Prognosis in Patients with Nsclc in Chinese Patients
16:45 - 18:00 | Presenter: Chunwei Xu | Author(s): Jinhuo Lai, Wenxian Wang, Quxia Zhang, Wu Zhuang, Yunjian Huang, Youcai Zhu, Yanping Chen, Gang Chen, Meiyu Fang, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-29 - An Intronic Variant in EGFR Regulates GBAS Expression and Predicts Survival in Early-Stage Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Eungbae Lee | Author(s): Mi Jeong Hong, Shin Yup Lee, Seung Soo Yoo, Jae Yong Park, Sukki Cho
- Abstract
Loading... -
+
P1.03-30 - The Number of Mutated Repair Genes as Predictor for Tumor Mutation Burden of Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Yuqing Lou | Author(s): Yanwei Zhang, Jianlin Xu, Xueyan Zhang, Wei Zhang, Rong Li, Baohui Han
- Abstract
Loading... -
+
P1.03-31 - Periostin is a Negative Prognostic Factor and Promotes Cancer Cell Proliferation in Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Toshimasa Okazaki | Author(s): Keiichi Tamai, Rie Shibuya, Mao Nakamura, Mai Mochizuki, Kazunori Yamaguchi, Jiro Abe, Satomi Takahashi, Kennichi Satoh
- Abstract
Loading... -
+
P1.03-32 - Molecular Characteristics and Prognosis FBXW7 Mutations in Chinese Non-Small-Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Chunwei Xu | Author(s): Wenxian Wang, Quxia Zhang, Wu Zhuang, Youcai Zhu, Yanping Chen, Meiyu Fang, Gang Chen, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-33 - Mutational Spectrum and Prognosis of Non-Small-Cell Lung Cancer Harboring MTOR Mutations in Chinese Population
16:45 - 18:00 | Presenter: Chunwei Xu | Author(s): Wenxian Wang, Quxia Zhang, Wu Zhuang, Youcai Zhu, Yanping Chen, Meiyu Fang, Gang Chen, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-34 - Combined Molecular and Radiological Evaluation Unveils Three Subtypes of Disease Progression to a Third Generation EGFR TKI
16:45 - 18:00 | Presenter: Yi-Chen Zhang | Author(s): Qing Zhou, Zhi-Hong Chen, Chong-Rui Xu, Jin -Ji Yang, Xu-Chao Zhang, Xiao-Yan Bai, Hong-Hong Yan, Wen -Feng Li, Shannon Chuai, Jun-Yi Ye, Han Zhang-Han, Zhou Zhang, Yi-Long Wu
- Abstract
Loading...
-
+
P1.04 - Immunooncology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.04-01 - Impact of Chromatin Remodeling Genes Including SMARCA2 and PBRM1 on Neoantigen and Immune Landscape of NSCLC
16:45 - 18:00 | Presenter: Young Kwang Chae | Author(s): Lee Chun Park, Sangmin Chang, Taeyoung Ko, Kyunghoon Rhee, Jonathan Anker, Manali Bhave, Andrew A. Davis, Marcelo Cruz, Wade Thomas Iams, Lihua Zou, Victor Wang, Jeffrey H Chuang
- Abstract
Loading... -
+
P1.04-02 - Targeting Established Lung Cancer Through Combination of DNT Cellular Therapy with PD1 Checkpoint Blockade
16:45 - 18:00 | Presenter: Linan Fang | Author(s): Dalam Ly, Wei Liu, Sisi Wang, Jong Lee, Heidi Kang, Li Zhang
- Abstract
Loading... -
+
P1.04-03 - Suppressive Immune Cell Profiling in Patients with Non-Small Cell Lung Cancer.
16:45 - 18:00 | Presenter: Jiae Koh | Author(s): Kyoung Young Lee, Boram Kim, Mi Soon Kim, Hee Jin Cho, Yeon Hee Bae, Bo Mi Ku, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
- Abstract
Loading... -
+
P1.04-04 - Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity
16:45 - 18:00 | Presenter: Chih-Hsiang Leng | Author(s): Chen-Yi Chiang, Chiao-Chieh Wu, Shih-Jen Liu, Hsin-Wei Chen
- Abstract
Loading... -
+
P1.04-05 - Elucidating the Role of Leukocyte-Associated Immunoglobin-Like Receptor 2 (LAIR2) in Lung Cancer Development
16:45 - 18:00 | Presenter: Dalam Ly | Author(s): Michael Cabanero, Chang-Qi Zhu, Ming Sound Tsao, Li Zhang
- Abstract
Loading... -
+
P1.04-06 - Clinicopathological Analysis of Pulmonary Pleomorphic Carcinoma
16:45 - 18:00 | Presenter: Misa Noguchi
- Abstract
Loading... -
+
P1.04-07 - Pemetrexed Enhances Anti-Tumor Efficacy of PD-L1 blockade by Promoting Intra-Tumor Immune Response via Tumor and T Cell-Intrinsic Mechanisms
16:45 - 18:00 | Presenter: Nelusha Amaladas | Author(s): David Schaer, Sandaruwan Geeganage, Zhao Hai Lu, Erik R. Rasmussen, Andreas Sonyi, Darin Chin, Andrew Capen, Yanxia Li, Catalina Maria Meyer, Bonita D Jones, Xiaodong Huang, Shuang Luo, Carmine Carpenito, Kenneth D Roth, Alexander Nikolayev, Bo Tan, Manisha Brahmachary, Krishna Chodavarapu, Frank Charles Dorsey, Jason R Manro, Thompson N. Doman, Gregory P Donoho, Gerald E Hall, Michael Kalos, Ruslan Novosiadly
- Abstract
Loading... -
+
P1.04-08 - Co-Residence of Patient-Derived Immune Cells in Patient-Derived Xenografts from Lung Cancer Patients
16:45 - 18:00 | Presenter: Xingxiang Pu | Author(s): Ran Zhang, Li Wang, Apar Pataer, Ismail M Meraz, Xiaoshan Zhang, Shuhong Wu, Yungchang Chen, Lin Wu, Dan Su, Weimin Mao, John V Heymach, Jack A Jack A. Roth, Stephen Swisher, Bingliang Fang
- Abstract
Loading... -
+
P1.04-09 - Immunomodulatory Effects of Afatinib and Pembrolizumab in EGFR-Mutant NSCLC with Progression on Prior EGFR-TKI
16:45 - 18:00 | Presenter: Jonathan W Riess | Author(s): Karen Kelly, Kurt Alex Schalper, Michiko Shimoda, Steffany Lim, Arta M Monjazeb, Kathleen Danenberg, Elizabeth H Moore, Laurel Beckett, Philip Christopher Mack, Emanual M Maverakis, David R. Gandara
- Abstract
Loading... -
+
P1.04-10 - The Importance of Suppressor and Cytotoxic T Lymphocyte Subsets and Cytotoxic Mechanisms in Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Akif Turna | Author(s): Esin Aktas, Ayşe Engin, Duygu İlke Çıkman, Gizem Ayan, Günnur Deniz
- Abstract
Loading... -
+
P1.04-11 - Exploring the Germ-Line Contribution to Exceptional Response to PD-1/PD-L1 Inhibition in Patients with NSCLC by Whole Genome Sequencing
16:45 - 18:00 | Presenter: Megan Babette Barnet | Author(s): Katherine J L Jackson, Bo Gao, Adnan Nagrial, Michael Boyer, Wendy Cooper, Rina Hui, Anthony Linton, Martin Henry Norman Tattersall, Amanda Russell, Greg Gibson, Jonathan Cebon, Georgina V Long, Alexander M Menzies, Richard A Scolyer, Paul Lacaze, Robert Brink, Timothy J Peters, Mark Cowley, Velimir Gayevskiy, David Thomas, Mark Pinese, Prunella Blinman, Steven Chuan-Hao Kao, Christopher Carl Goodnow
- Abstract
Loading... -
+
P1.04-12 - Mass Spectrometry-Based Serum Proteomic Signature as a Potential Biomarker for Survival in NSCLC Patients with Immunotherapy
16:45 - 18:00 | Presenter: Young Kwang Chae | Author(s): Won Bin Kim, Nicholas I. Simon, Kyunghoon Rhee, Junho Song, Anderson Cho, Michael Oh, Wade Thomas Iams, Andrew A. Davis, Jonathan Anker, Lee Chun Park
- Abstract
Loading... -
+
P1.04-13 - Combining Clinical and Genomic Data for Predicting Response to Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Michelle Chiu | Author(s): Mary Beth Lipka, Priyanka Bhateja, Afshin Dowlati
- Abstract
Loading... -
+
P1.04-14 - HLA B44 Supertype Associated with Less Favorable Neoantigen Binding in Non-Small Cell Lung Cancer Treated with Immunotherapy
16:45 - 18:00 | Presenter: Amy Cummings | Author(s): Henry Lu, Jaklin Gukasyan, John Madrigal, James Carroll, Krikor Bornazyan, Benjamin Jones, Zorawar Noor, Aaron Lisberg, Jonathan W. Goldman, Siwen Hu-Lieskovan, Steven M Dubinett, Edward B Garon
- Abstract
Loading... -
+
P1.04-15 - Computerized Tomography Texture Analysis as Biomarker of Benefit from Nivolumab in Advanced Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Carlo Genova | Author(s): Emanuele Barabino, Gianluca Ficarra, Marta Verda, Erika Rijavec, Giovanni Rossi, Marco Tagliamento, Federica Biello, Giulia Barletta, Maria Giovanna Dal Bello, Giuseppe Cittadini, Francesco Grossi
- Abstract
Loading... -
+
P1.04-16 - Comparison of Clinical Response to Checkpoint Inhibitors in Advanced NSCLC with High PD-L1 Expression Tested on Cytology Versus Biopsy Samples
16:45 - 18:00 | Presenter: Katie Guo | Author(s): Goulnar Kasymjanova, Hangjun Wang, Lama Sakr, David Small, Victor Cohen, Carmela Pepe, Alan Spatz, Jason S Agulnik
- Abstract
Loading... -
+
P1.04-17 - Tumour Burden as a Predictive Tool of Response to Immune Checkpoint Inhibitors (ICI) in Patients with Metastatic Non-Small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Oded Icht | Author(s): Liran Domachevsky, David Groshar, Elizabeth Dudnik, Ofer Rotem, Nir Peled, Daniel Reinhorn, Oded Jacobi, Tzippy Shochat, Hanna Bernstine, Alona Zer
- Abstract
Loading... -
+
P1.04-18 - PD-L1 Expression and its Correlation with Tumor TNM Stage in Patients with Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Taewon Jang | Author(s): Jehun Kim
- Abstract
Loading... -
+
P1.04-19 - Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict Survival After Immunotherapy in Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Young Kwang Chae | Author(s): Michael Oh, Diana Saravia, Sarita Agte, Ashkon Alexander Rahbari, Wungki Park, Gilberto de Lima Lopes
- Abstract
Loading... -
+
P1.04-20 - Computational Biological Model Prediction of PD-L1 Expression and Immunotherapy Response for KRAS Mutated Lung Cancer Based on Co-Mutations
16:45 - 18:00 | Presenter: Sukhmani Kaur Padda | Author(s): Jacqueline Virginia Aredo, Shireen Vali, Neeraj Kumar Singh, Sumanth M Vasista, Upasana Mitra, Taher Abbasi, Heather A Wakelee
- Abstract
Loading... -
+
P1.04-21 - The Utility of PD-L1/CD8 Dual Immunohistochemistry for Prediction of Response to Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
16:45 - 18:00 | Presenter: Mari Mino-Kenudson | Author(s): Matthew Rosenbaum, Sara Khosrowjerdi, Vashine Kamesan, Subba Digumarthy, Justin F Gainor
- Abstract
Loading... -
+
P1.04-22 - CD73 Immunohistochemical Expression in Malignant Cells and Correlation with Immune Infiltrate in Non-Small Cell Lung Carcinoma (NSCLC).
16:45 - 18:00 | Presenter: Ignacio I. Wistuba | Author(s): Ruth Salazar, Jose Luis Solorzano, Luisa Solis, Carmen Behrens, Barbara Mino, Edwin Roger Parra, Jianjun Zhang, Ara A Vaporciyan, David Rice, Neda Kalhor, Cesar Moran, Don Lynn Gibbons, Annikka Weissferdt, Boris Sepesi
- Abstract
Loading... -
+
P1.04-23 - Expression of Emerging Immunotherapy Targets in Early-Stage Squamous Lung Carcinoma
16:45 - 18:00 | Presenter: Hui Yu | Author(s): Zhengming Chen, Karla Ballman, Mark Watson, Ramaswamy Govindan, David Beer, Raphael Bueno, Michael Herman, Wilbur A. Franklin, David R. Gandara, Mary-Beth Moore Joshi, Daniel T Merrick, William G Richards, Christopher J. Rivard, Frances A Shepherd, Ming Sound Tsao, Adrian van Bokhoven, David Harpole, Fred R. Hirsch
- Abstract
Loading... -
+
P1.04-24 - Digital Core Needle-Biopsy to Assess PD-L1 Expression in Non-Small Cell Lung Cancer: Optimal Sampling and Need for Re-Biopsy
16:45 - 18:00 | Presenter: Alexander Haragan | Author(s): John Kirkpatrick Field, Michael P A Davies, Carles Escriu, Aaron Gruver, John Roy Gosney
- Abstract
Loading... -
+
P1.04-25 - The Implication of Frameshift Mutation Burden in Neoantigen and Immune Cell Landscape in Non-Small Cell Lung Cancer (NSCLC)
16:45 - 18:00 | Presenter: Young Kwang Chae | Author(s): Sangmin Chang, Taeyoung Ko, Kyunghoon Rhee, Marcelo Cruz, Manali Bhave, Jonathan Anker, Andrew A. Davis, Wade Thomas Iams, Victor Wang, Jeffrey H Chuang, Lee Chun Park
- Abstract
Loading... -
+
P1.04-26 - Prospective Immuno-Biobank in NSCLC
16:45 - 18:00 | Presenter: Alfredo Addeo | Author(s): Celine Py, Garance Gutknecht, Alex Friedlander, Aurelie Vuilleumier, Pierre-Yves Dietrich
- Abstract
Loading... -
+
P1.04-27 - Safety of Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) in the Real-Life Setting: A Single-Institution Experience from Argentina.
16:45 - 18:00 | Presenter: Maria Virginia Bluthgen | Author(s): Mercedes Tamburelli, Carlos Calderon, Javier Castillo, Carlos Bas, Gonzalo Gomez Abuin, Susana Sena
- Abstract
Loading... -
+
P1.04-28 - Baseline Markers of Inflammation and Outcome with Nivolumab in Pretreated Non Small Cell Lung Cancers: A Retrospective Study.
16:45 - 18:00 | Presenter: Alessandro Russo | Author(s): Alessandra Battaglia, Giusy Provazza, Giuseppe Lo Certo, Giuseppina Rosaria Rita Ricciardi, Maria Picciotto, Antonino Scimone, Giuseppe Toscano, Vincenzo Adamo, Tindara Franchina
- Abstract
Loading... -
+
P1.04-29 - Second or Third Line Nivolumab Versus First Line Nivolumab in Patients with Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)
16:45 - 18:00 | Presenter: Antonio Irigoyen Medina | Author(s): Elia Martinez Moreno, Ruth Alvarez Cabellos, Katherin Aly Barroso Martinez, Jesus Andrade Santiago, Miguel Borregon Rivilla, Juan David Cardenas, Carmen Esteban, Blanca Trujillo, Adriana Rosero, Lourdes Fernandez, Irene Ramos, Alba Ramos, Jose Ignacio Chacon
- Abstract
Loading... -
+
P1.04-30 - A Potential Effect of Diabetes Mellitus and Metformin Use on Efficacy of Immune Checkpoint Inhibitors (ICI)
16:45 - 18:00 | Presenter: Oded Jacobi | Author(s): Yosef Landman, Daniel Reinhorn, Oded Icht, Elizabeth Dudnik, Ofer Rotem, Victoria Neiman, Michal Sarfaty, Inbar Finkel, Daniel Hendler, Nir Peled, Alona Zer
- Abstract
Loading... -
+
P1.04-31 - Efficacy and Tolerance of Immune-Checkpoint Inhibitors in EGFR, ALK/ROS 1 Non-Small-Cell-Lung-Cancer (NSCLC): GFPC 03-2016 IMAD Study
16:45 - 18:00 | Presenter: Olivier Bylicki | Author(s): Florian Guisier, Isabelle Monnet, Helene Doubre, Radj Gervais, Henri Janicot, Maurice Pérol, Pierre Fournel, Jacques Le Treut, Regine Lamy, Sabine Vieillot, Herve Le Caer, Jean-Bernard Auliac, Christos Chouaid
- Abstract
Loading... -
+
P1.04-32 - Phase I/II Study of the A2AR Antagonist NIR178 (PBF-509), an Oral Immunotherapy, in Patients (pts) with Advanced NSCLC
16:45 - 18:00 | Presenter: Alberto A. Chiappori | Author(s): Charles C. Williams, Ben C. Creelan, Tawee T Tanvetyanon, Jhanelle Elaine Gray, Eric B. Haura, Dung Tsa Chen, Ram Thapa, Amer Beg, Theresa Boyle, Mansee Sangani, Eric Morris, Aiyang Tao, Felipe Hurtado, Luigi Manenti, Julio Castro, Scott J Antonia
- Abstract
Loading... -
+
P1.04-33 - Retrospective Descriptive Analysis of Metformin with Atezolizumab in Advanced Non-Small Cell Lung Cancer in The OAK Trial
16:45 - 18:00 | Presenter: Richard Pietras | Author(s): Hao Xu, Xiaoping Hu, Christina Matheny, Alan Sandler, Manish Patel
- Abstract
Loading... -
+
P1.04-34 - Study on Treatment of Stage IV Solid Tumors with Mutant Neoantigen Specific T Cells
16:45 - 18:00 | Presenter: Song Qi | Author(s): Jin Song, Sun Shengjie, Qin Boyu, Zhang Xiaoling, Huaibo Sun, Yuqi Wang, Yanfang Guan, Xuefeng Xia, Yi Xin, Jiao Shunchang
- Abstract
Loading... -
+
P1.04-35 - Quick Progression (QP) in Patients Treated by Nivolumab (IO) in 2nd Line or More for Non-Small Cell Lung Cancer: ERORECI Study (GFPC 2016-04)
16:45 - 18:00 | Presenter: Alain Vergnenegre | Author(s): Margaux Geier, Florian Guisier, Regine Lamy, Bénédicte Comet, Gwenaelle Le Garff, Pascal Do, Henri Janicot, Hugues Morel, Chantal Decroisette, Michel Andre, Lionel Falchero, Nicolas Paleiron, Isabelle Monnet
- Abstract
Loading... -
+
P1.04-36 - Tislelizumab Combined With Chemotherapy as First-Line Treatment in Chinese Patients With Advanced Lung Cancer
16:45 - 18:00 | Presenter: Jie Wang | Author(s): Jun Zhao, Zhijie Wang, Zhiyong Ma, Jiuwei Cui, Yongqian Shu, Zhe Liu, Ying Cheng, Shiang Jiin Leaw, Jian Li, Fan Xia
- Abstract
Loading...